Viewing Study NCT02808403


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2025-12-28 @ 11:20 AM
Study NCT ID: NCT02808403
Status: COMPLETED
Last Update Posted: 2024-11-21
First Post: 2016-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-06-24
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-30
Completion Date Type: ACTUAL
First Submit Date: 2016-06-07
First Submit QC Date: None
Study First Post Date: 2016-06-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-20
Last Update Post Date: 2024-11-21
Last Update Post Date Type: ACTUAL